5-Hydroxyindoleacetic acid

From WikiMD's WELLNESSPEDIA

(Redirected from 5-hydroxyindoleacetic acid)

A metabolite of serotonin


5-Hydroxyindoleacetic acid (5-HIAA) is a primary metabolite of serotonin, a key neurotransmitter in the central nervous system. It is commonly measured in the urine to assess serotonin levels in the body and is used in the diagnosis of various medical conditions.

Biochemistry[edit]

5-Hydroxyindoleacetic acid is produced from serotonin through the action of the enzyme monoamine oxidase (MAO), followed by oxidation. The process begins with the conversion of serotonin to 5-hydroxyindoleacetaldehyde, which is then oxidized to form 5-HIAA. This metabolic pathway is crucial for the regulation of serotonin levels in the body.

Clinical significance[edit]

The measurement of 5-HIAA in the urine is an important diagnostic tool. Elevated levels of 5-HIAA can indicate the presence of a carcinoid tumor, which is a type of neuroendocrine tumor that secretes large amounts of serotonin. These tumors are often found in the gastrointestinal tract and can lead to a condition known as carcinoid syndrome, characterized by flushing, diarrhea, and heart valve lesions.

Testing[edit]

Urinary 5-HIAA levels are typically measured using a 24-hour urine collection. Patients are often advised to avoid certain foods and medications that can interfere with the test, such as bananas, avocados, and certain cough medicines, as these can artificially elevate 5-HIAA levels.

Pathophysiology[edit]

In addition to carcinoid tumors, other conditions can affect 5-HIAA levels. For example, malabsorption syndromes and liver disease can alter serotonin metabolism and subsequently affect 5-HIAA excretion. Conversely, low levels of 5-HIAA may be seen in conditions such as depression and Parkinson's disease, where serotonin metabolism is impaired.

Related pages[edit]

Gallery[edit]

5-Hydroxyindoleacetic acid[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.